Hamatake Makiko, Nishizawa Masako, Yamamoto Naoki, Kato Shingo, Sugiura Wataru
Department of Molecular Virology, Tokyo Medical Dental University, Bunkyo, Tokyo 1138510, Japan.
J Virol Methods. 2007 Jun;142(1-2):113-7. doi: 10.1016/j.jviromet.2007.01.012. Epub 2007 Mar 23.
An easy, inexpensive competitive RT-PCR assay for HIV-1 RNA quantitation was constructed. A 138-bp sequence in the HIV-1 gag p24 region was selected as the target and co-amplified with competitor RNA containing an internal 44-bp deletion. Quantitation of serial dilutions of control RNA samples prepared from the LAI isolate demonstrated a good linearity (R(2)=0.991) within the range between 10 and 250 copies/sample. The detection limit of the assay was determined to be 3.8 copies/sample by Probit analysis and corresponded to 110 copies/ml in plasma. The intra-assay CV value was 9.1%, and the inter-assay value was 25.9%. Both were comparable to those obtained with commercially available HIV-1 RNA quantitation kits. The correlation efficient for the results obtained in 47 plasma samples from HIV-1-infected individuals (subtype A in 1, subtype B in 25, subtype C in 4, subtype F in 1, and CRF01 AE in 16) with the competitive RT-PCR and Cobas Amplicor HIV-1 Monitor test v1.5 was 0.956 for subtype B and 0.947 for subtype non-B. The assay devised is a good alternative for monitoring antiretroviral therapy in resource-poor countries.
构建了一种用于HIV-1 RNA定量的简便、廉价的竞争性RT-PCR检测方法。选择HIV-1 gag p24区域中的一段138 bp序列作为靶标,并与含有内部44 bp缺失的竞争RNA共同扩增。对从LAI分离株制备的对照RNA样品进行系列稀释定量,结果表明在10至250拷贝/样品范围内具有良好的线性关系(R(2)=0.991)。通过概率分析确定该检测方法的检测限为3.8拷贝/样品,相当于血浆中110拷贝/ml。批内CV值为9.1%,批间值为25.9%。两者均与市售HIV-1 RNA定量试剂盒获得的值相当。对47份来自HIV-1感染个体(1例A亚型、25例B亚型、4例C亚型、1例F亚型和16例CRF01 AE亚型)的血浆样本,采用竞争性RT-PCR和Cobas Amplicor HIV-1 Monitor test v1.5检测结果的相关系数,B亚型为0.956,非B亚型为0.947。所设计的检测方法是资源匮乏国家监测抗逆转录病毒治疗的良好替代方法。